The RGS2 (-391, C>G) Genetic Variation Correlates to Antihypertensive Drug Responses in Chinese Patients with Essential Hypertension

• Fazhong He,

  Affiliations Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C, Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C, Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C

  ⨯
• Jianquan Luo,

  Affiliations Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C, Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C, Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C

  ⨯
• Zhitao Zhang,

  Affiliation Second uropoiesis surgical department in Han Dan Central Hospital, Handan, P.R.C

  ⨯
• Zhiying Luo,

  Affiliations Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C, Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C, Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C

  ⨯
• Lan Fan,

  Affiliations Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C, Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C, Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C

  ⨯
• Yijing He,

  Affiliations Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C, Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C, Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C

  ⨯
• Jiagen Wen,

  Affiliations Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C, Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C, Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C

  ⨯
• Dingilang Zhu,

  Affiliation Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R.C

  ⨯
• Jinping Gao,

  Affiliation Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R.C

  ⨯
• Yan Wang,

  Affiliation Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R.C

  ⨯
• Yuesheng Qian,

  Affiliation Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R.C

  ⨯
• Honghao Zhou,

  Affiliations Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C, Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C, Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C

  ⨯
• Xiaoping Chen ,

  * E-mail: yjsd2003@163.com (WZ); chenxp74@hotmail.com (XC)

  Affiliations Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C, Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C, Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C

  ⨯
• Wei Zhang

  * E-mail: yjsd2003@163.com (WZ); chenxp74@hotmail.com (XC)

  Affiliations Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C, Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C, Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C

  ⨯